Related Experiment Video
Updated: Feb 25, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Pharmacological Therapy for Rate and Rhythm Control for Atrial Fibrillation in 2017
Logan Kanagaratnam1, Peter Kowey2, David Whalley3
1Department of Cardiology, Royal North Shore Hospital, Sydney, NSW, Australia; University of Sydney, Sydney, NSW, Australia; Ryde Hospital, Sydney, NSW, Australia.
Abstract:
In spite of the emergence of non-pharmacological approaches, medical therapy remains the primary modality of treatment for most patients with atrial fibrillation (AF). This review will look at evidence for rate and rhythm control approaches, and at factors that would help in choosing the appropriate treatment strategy for individual patients.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

